Institutional investors hold a majority ownership of AMGN through the 82.09% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LVM CAPITAL MANAGEMENT LTD. Bought 75.3 Thousand shares of Amgen
INTERMEDE INVESTMENT PARTNERS LT... Bought 67.0 Thousand shares of Amgen
NORDEA INVESTMENT MANAGEMENT AB ... Bought 65.2 Thousand shares of Amgen